Clinical Trial Update: NCGENES: North Carolina Clinical Genomic Evaluation by NextGen Exome Sequencing [NA]

View source ↗

Summary

The NCGENES study evaluating clinical genomic evaluation by next-generation exome sequencing has completed, with conditions including cancer, cardiovascular dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Cardiovascular Disease
• Congenital Disorders
• Hearing Loss
• Neurological Disorders

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Cancer, Cardiovascular Disease | NA | Status: COMPLETED